133 related articles for article (PubMed ID: 4086157)
1. Endometrial papillary adenocarcinomas: two clinicopathological types.
Chen JL; Trost DC; Wilkinson EJ
Int J Gynecol Pathol; 1985; 4(4):279-88. PubMed ID: 4086157
[TBL] [Abstract][Full Text] [Related]
2. Malignant papillary lesions of the endometrium.
Sutton GP; Brill L; Michael H; Stehman FB; Ehrlich CE
Gynecol Oncol; 1987 Jul; 27(3):294-304. PubMed ID: 3623228
[TBL] [Abstract][Full Text] [Related]
3. Papillary carcinomas of the endometrium.
Ward BG; Wright RG; Free K
Gynecol Oncol; 1990 Dec; 39(3):347-51. PubMed ID: 2258082
[TBL] [Abstract][Full Text] [Related]
4. Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma.
Hendrickson M; Ross J; Eifel P; Martinez A; Kempson R
Am J Surg Pathol; 1982 Mar; 6(2):93-108. PubMed ID: 7102898
[TBL] [Abstract][Full Text] [Related]
5. Papillary serous adenocarcinoma of the endometrium: a clinicopathologic study of 19 cases.
Lee KR; Belinson JL
Gynecol Oncol; 1992 Jul; 46(1):51-4. PubMed ID: 1634141
[TBL] [Abstract][Full Text] [Related]
6. Virulence factors in endometrial cancer.
Gusberg SB
Cancer; 1993 Feb; 71(4 Suppl):1464-6. PubMed ID: 8431881
[TBL] [Abstract][Full Text] [Related]
7. Outcome and patterns of failure in pathologic stages I-IV clear-cell carcinoma of the endometrium: implications for adjuvant radiation therapy.
Murphy KT; Rotmensch J; Yamada SD; Mundt AJ
Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1272-6. PubMed ID: 12654437
[TBL] [Abstract][Full Text] [Related]
8. Management of early stage endometrial papillary adenocarcinoma.
Ampil F; Ridenour C; Abreo F
J La State Med Soc; 1991 Jan; 143(1):22-7. PubMed ID: 2002268
[TBL] [Abstract][Full Text] [Related]
9. Papillary adenocarcinoma in the endometrium.
Ramirez-Gonzalez CE; Adamsons K; Mangual-Vazquez TY; Wallach RC
Obstet Gynecol; 1987 Aug; 70(2):212-5. PubMed ID: 3601285
[TBL] [Abstract][Full Text] [Related]
10. [Serous papillary adenocarcinoma of the endometrium].
Lampe B; Kürzl R; Kindermann G
Geburtshilfe Frauenheilkd; 1991 Jan; 51(1):45-50. PubMed ID: 2026299
[TBL] [Abstract][Full Text] [Related]
11. The significance of the pathologic findings in endometrial cancer.
Christopherson WM
Clin Obstet Gynaecol; 1986 Dec; 13(4):673-93. PubMed ID: 3024898
[TBL] [Abstract][Full Text] [Related]
12. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA
Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441
[TBL] [Abstract][Full Text] [Related]
13. [Predictors of recurrence and prognosis in patients with stage I and II endometrial carcinoma].
Li M; Wang Z; Zhao L; Li X; Wang J; Zhang C; Wei L
Zhonghua Fu Chan Ke Za Zhi; 2014 Jun; 49(6):455-9. PubMed ID: 25169640
[TBL] [Abstract][Full Text] [Related]
14. Tubal (serous) carcinoma of the endometrium.
Lauchlan SC
Arch Pathol Lab Med; 1981 Nov; 105(11):615-8. PubMed ID: 6895302
[TBL] [Abstract][Full Text] [Related]
15. Uterine serous carcinoma. A morphologically diverse neoplasm with unifying clinicopathologic features.
Sherman ME; Bitterman P; Rosenshein NB; Delgado G; Kurman RJ
Am J Surg Pathol; 1992 Jun; 16(6):600-10. PubMed ID: 1599038
[TBL] [Abstract][Full Text] [Related]
16. Uterine Papillary Serous Carcinoma: A Single-Institution Review of 62 Cases.
Black C; Feng A; Bittinger S; Quinn M; Neesham D; McNally O
Int J Gynecol Cancer; 2016 Jan; 26(1):133-40. PubMed ID: 26588230
[TBL] [Abstract][Full Text] [Related]
17. Carcinoma of the endometrium. II. Papillary adenocarcinoma: a clinical pathological study, 46 cases.
Christopherson WM; Alberhasky RC; Connelly PJ
Am J Clin Pathol; 1982 May; 77(5):534-40. PubMed ID: 7081149
[TBL] [Abstract][Full Text] [Related]
18. Papillary serous adenocarcinoma of the endometrium.
Jeffrey JF; Krepart GV; Lotocki RJ
Obstet Gynecol; 1986 May; 67(5):670-4. PubMed ID: 3960439
[TBL] [Abstract][Full Text] [Related]
19. Improved outcome at 10 years for serous-papillary/clear cell or high-risk endometrial cancer patients treated by adjuvant high-dose whole abdomino-pelvic irradiation.
Martinez AA; Weiner S; Podratz K; Armin AR; Stromberg JS; Stanhope R; Sherman A; Schray M; Brabbins DA
Gynecol Oncol; 2003 Sep; 90(3):537-46. PubMed ID: 13678721
[TBL] [Abstract][Full Text] [Related]
20. Ten-year outcome including patterns of failure and toxicity for adjuvant whole abdominopelvic irradiation in high-risk and poor histologic feature patients with endometrial carcinoma.
Stewart KD; Martinez AA; Weiner S; Podratz K; Stromberg JS; Schray M; Mitchell C; Sherman A; Chen P; Brabbins DA
Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):527-35. PubMed ID: 12243832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
